Hyperbaric oxygen therapy in the management of crush injuries: A randomized double-blind placebo-controlled clinical trial

被引:148
|
作者
Bouachour, G [1 ]
Cronier, P [1 ]
Gouello, JP [1 ]
Toulemonde, JL [1 ]
Talha, A [1 ]
Alquier, P [1 ]
机构
[1] CHU ANGERS,SERV CHIRURG RECONSTRUCT & TRAUMATOL,F-49033 ANGERS 01,FRANCE
来源
JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE | 1996年 / 41卷 / 02期
关键词
D O I
10.1097/00005373-199608000-00023
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Hyperbaric Oxygen (HBO) therapy is advocated for the treatment of severe trauma of the limbs in association with surgery because of its effects on peripheral oxygen transport, muscular ischemic necrosis, compartment syndrome, and infection prevention, However, no controlled human trial had been performed until now to specify the role of HBO in the management of crush injuries, Thirty-six patients with crush injuries were assigned in a blinded randomized fashion, within 24 hours after surgery, to treatment with HBO (session of 100% O-2 at 2.5 atmosphere absolute (ata) for 90 minutes, twice daily, over 6 days) or placebo (session of 21% O-2 at 1.1 ata for 90 minutes, twice daily, over 6 days), All the patients received the same standard therapies (anticoagulant, antibiotics, wound dressings), Transcutaneous oxygen pressure (PtCO2) measurements were done before (patient breathing normal air) and during treatment (HBO or placebo) at the first, fourth, eighth, and twelfth sessions, The two groups (HBO group, n = 18; placebo group, n = 18) were similar in terms of age; risk factors; number, type or location of vascular injuries, neurologic injuries, or fractures; and type, location, or timing of surgical procedures, Complete healing was obtained for 17 patients in the HBO group vs, 10 patients in the placebo group (p < 0.01), New surgical procedures (such as skin flaps and grafts, vascular surgery, or even amputation) were performed on one patient in the HBO group vs, six patients in the placebo group (p < 0.05), Analysis of groups of patients matched for age and severity of injury showed that in the subgroup of patients older than 40 with grade III soft-tissue injury, wound healing was obtained for seven patients (87.5%) in the HBO group vs, three patients (30%) in the placebo group (p < 0.05), No significant differences were found in the length of hospital stay and number of wound dressings between groups, For the patients with complete healing, the PtCO2 values of the traumatized limb, measured in normal air, rose significantly between the first and the twelfth sessions (p < 0.001). No significant change in PtCO2 value was found for the patients whose healing failed, The Bilateral Perfusion Index (BPI = PtCO2 of the injured limb/PtCO2 of the uninjured limb) at the first session increased significantly from 1 ata air to 2.5 ata O-2 (p < 0.05), In patients with complete healing, the BPI was constantly greater than 0.9 at 2.5 ata O-2 during the following sessions, whereas the BPI in air progressively rose between the first and the twelfth sessions (p < 0.05), reaching normal values at the end of the treatment, In conclusion, this study shows the effectiveness of HBO in improving wound healing and reducing repetitive surgery, We believe that HBO is a useful adjunct in the management of severe (grade III) crush injuries of the limbs in patients more than 40 years old.
引用
收藏
页码:333 / 339
页数:7
相关论文
共 50 条
  • [21] Marfan Sartan: a randomized, double-blind, placebo-controlled trial
    Milleron, Olivier
    Arnoult, Florence
    Ropers, Jacques
    Aegerter, Philippe
    Detaint, Delphine
    Delorme, Gabriel
    Attias, David
    Tubach, Florence
    Dupuis-Girod, Sophie
    Plauchu, Henry
    Barthelet, Martine
    Sassolas, Francois
    Pangaud, Nicolas
    Naudion, Sophie
    Thomas-Chabaneix, Julie
    Dulac, Yves
    Edouard, Thomas
    Wolf, Jean-Eric
    Faivre, Laurence
    Odent, Sylvie
    Basquin, Adeline
    Habib, Gilbert
    Collignon, Patrick
    Boileau, Catherine
    Jondeau, Guillaume
    EUROPEAN HEART JOURNAL, 2015, 36 (32) : 2160 - U37
  • [22] A double-blind, randomized, placebo-controlled laser trial methodology
    Oussedik, E.
    Saleem, M. D.
    Patel, N. U.
    Feldman, S. R.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2017, 137 (10) : B11 - B11
  • [23] A randomized, double-blind, placebo-controlled trial of pseudoephedrine in coryza
    Latte, J
    Taverner, D
    Slobodian, P
    Shakib, S
    CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 2004, 31 (07): : 429 - 432
  • [24] Comment on "Hyperbaric oxygen therapy for radionecrosis of the jaw: A randomized, placebo-controlled, double-blind trial from the ORN96 study group
    van Merkesteyn, R
    Bakker, DJ
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (19) : 4465 - 4466
  • [25] A Randomized, Double-Blind, Placebo-Controlled Clinical Effect of a Xanthone-rich Dietary Supplement on Immune Function in Humans: A Randomized Double-Blind Placebo-Controlled Trial
    Tang, Yu-Ping
    Li, Peng-Gao
    Ji, Hongping
    Kou, Yan
    FASEB JOURNAL, 2008, 22
  • [26] Management of uninvestigated dyspepsia: A randomized, double-blind, placebo-controlled trial of proton pump inhibitor therapy
    Rabeneck, L
    Souchek, J
    Wristers, K
    Menke, T
    Wray, N
    Ambriz, E
    Huang, I
    GASTROENTEROLOGY, 2001, 120 (05) : A88 - A88
  • [27] Efficacy of sodium butyrate adjunct therapy in shigellosis: a randomized, double-blind, placebo-controlled clinical trial
    Raqib, Rubhana
    Sarker, Protim
    Mily, Akhirunnesa
    Alam, Nur Haque
    Arifuzzaman, Abu Saleh Mohammed
    Rekha, Rokeya Sultana
    Andersson, Jan
    Gudmundsson, Gudmundur H.
    Cravioto, Alejandro
    Agerberth, Birgitta
    BMC INFECTIOUS DISEASES, 2012, 12
  • [28] Simvastatin as an Adjunctive Therapy to Risperidone in Treatment of Autism: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial
    Moazen-Zadeh, Ehsan
    Shirzad, Fatemeh
    Karkhaneh-Yousefi, Mohammad-Ali
    Khezri, Rasoul
    Mohammadi, Mohammad-Reza
    Akhondzadeh, Shahin
    JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2018, 28 (01) : 82 - 89
  • [29] Efficacy of sodium butyrate adjunct therapy in shigellosis: a randomized, double-blind, placebo-controlled clinical trial
    Rubhana Raqib
    Protim Sarker
    Akhirunnesa Mily
    Nur Haque Alam
    Abu Saleh Mohammed Arifuzzaman
    Rokeya Sultana Rekha
    Jan Andersson
    Gudmundur H Gudmundsson
    Alejandro Cravioto
    Birgitta Agerberth
    BMC Infectious Diseases, 12
  • [30] Neurocysticercosis in children: clinical therapy in a randomized, double-blind, placebo-controlled trial in newly diagnosed cases
    Gogia, S
    Talukdar, B
    Choudhury, V
    Arora, BS
    TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE, 2003, 97 (04) : 416 - 421